Inhibition of the sodium/potassium ATPase impairs N-glycan expression and function

Cancer Research

Volumn 68, Issue 16, 2008, Pages 6688-6697

  Zavareh, Reza Beheshti ^a,b   Lau, Ken S ^c   Hurren, Rose ^a   Datti, Alessandro ^b   Ashline, David J ^e   Gronda, Marcela ^a   Cheung, Pam ^c   Simpson, Craig D ^a,b   Liu, Wei ^a   Wasylishen, Amanda R ^a,b   Boutros, Paul C ^a,b   Shi, Hui ^a   Vengopal, Amudha ^a   Jurisica, Igor ^a,b   Penn, Linda Z ^a,b   Reinhold, Vern N ^e   Ezzat, Shereen ^a,b   Wrana, Jeff ^c   Rose, David R ^a,b   Schachter, Harry ^d   Dennis, James W ^c   Schimmer, Aaron D ^a,b,f   more..

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF NEW HAMPSHIRE   (United States)

^f 610 University Avenue ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; CARDIAC GLYCOSIDE; CONCANAVALIN A; DIGITOXIGENIN; DIGITOXIN; DIGOXIN; DIHYDROOUABAIN; GLYCAN DERIVATIVE; GLYCOPROTEIN; OLIGOSACCHARIDE; PHYTOHEMAGGLUTININ L; PLANT LECTIN; UNCLASSIFIED DRUG; DIGITALIS GLYCOSIDE; ENZYME INHIBITOR; GLYCOPEPTIDE; PHYTOHEMAGGLUTININ; POLYSACCHARIDE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; CARCINOGENESIS; CELL AGGLUTINATION; CELL DEATH; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; ENZYME INHIBITION; GLYCOSYLATION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; ANIMAL; CELL CULTURE; CELL MOTION; CELL SURVIVAL; COMBINATORIAL CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETIC TRANSFECTION; MASS SPECTROMETRY; METABOLISM; MOUSE MUTANT; NEOPLASM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

ANIMALS; CELL MOVEMENT; CELL SURVIVAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DIGITALIS GLYCOSIDES; ENZYME INHIBITORS; GLYCOPEPTIDES; GLYCOSYLATION; HUMANS; MALE; MICE; MICE, SCID; NEOPLASMS; PHYTOHEMAGGLUTININS; POLYSACCHARIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SODIUM-POTASSIUM-EXCHANGING ATPASE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TRANSFECTION; TUMOR CELLS, CULTURED; WOUND HEALING;

EID: 53049106681     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-6833     Document Type: Article

References (40)

1. Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34.
2. Lau KS, Partridge EA, Grigorian A, et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007; 129:123-34.
3. Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, Nabi IR. Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol 2006;26:3181-93.
4. Lajoie P, Partridge EA, Guay G, et al. Plasma membrane domain organization regulates EGFR signaling in tumor cells. J Cell Biol 2007;179:341-56.
5. Goss PE, Baker MA, Carver JP, Dennis JW. Inhibitors of carbohydrate processing: A new class of anticancer agents. Clin Cancer Res 1995;1:935-44.
6. Hakomori S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res 1996;56:5309-18.
7. Kornfeld R, Kornfeld S. Assembly of asparaginelinked oligosaccharides. Annu Rev Biochem 1985;54:631-64.
8. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of proteinbound oligosaccharides. Adv Exp Med Biol 1986;205:53-85.
9. Datti A, Donovan RS, Korczak B, Dennis JW. A homogeneous cell-based assay to identify N-linked carbohydrate processing inhibitors. Anal Biochem 2000;280:137-42.
10. Mawji IA, Simpson CD, Gronda M, et al. A chemical screen identifies anisomycin as an anoikis sensitizer that functions by decreasing FLIP protein synthesis. Cancer Res 2007;67:8307-15.
11. Storey JD. A direct approach to false discovery rates. J R Stat Soc B 2002;64:479-98.
12. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956;28:350-6.
13. Schimmer AD, Thomas MP, Hurren R, et al. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors. Cancer Res 2006;66:2367-75.
14. Sarkar M, Leventis PA, Silvescu CI, Reinhold VN, Schachter H, Boulianne GL. Null mutations in Drosophila N-acetylglucosaminyltransferase I produce defects in locomotion and a reduced life span. J Biol Chem 2006; 281:12776-85.
15. Liu W, Wei W, Winer D, et al. CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases. Oncogene 2007;26:2747-58.
16. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 1995;130:383-92.
17. Cairns RA, Hill RP. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 2004; 64:2054-61.
18. Green ED, Baenziger JU. Oligosaccharide specificities of Phaseolus vulgaris leukoagglutinating and erythroagglutinating phytohemagglutinins. Interactions with N-glycanase-released oligosaccharides. J Biol Chem 1987;262:12018-29.
19. Doherty JE. Clinical use of digitalis glycosides. An update. Cardiology 1985;72:225-54.
20. Stenkvist B, Bengtsson E, Eklund G, et al. Evidence of a modifying influence of heart glucosides on the development of breast cancer. Anal Quant Cytol 1980;2:49-54.
21. Stenkvist B, Pengtsson E, Dahlqvist B, Eriksson O, Jarkrans T, Nordin B. Cardiac glycosides and breast cancer, revisited. N Engl J Med 1982;306:484.
22. Brown L, Erdmann E, Thomas R. Digitalis structureactivity relationship analyses. Conclusions from indirect binding studies with cardiac (Na++ K+)-ATPase. Biochem Pharmacol 1983;32:2767-74.
23. Johansson S, Lindholm P, Gullbo J, Larsson R, Bohlin L, Claeson P. Cytotoxicity of digitoxin and related cardiac glycosides in human tumor cells. Anticancer Drugs 2001;12:475-83.
24. Raghavendra PB, Sreenivasan Y, Ramesh GT, Manna SK. Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases. Apoptosis 2007;12:307-18.
25. Thomas R, Gray P, Andrews J. Digitalis: its mode of action, receptor, and structure-activity relationships. Adv Drug Deliv Rev 1990;19:313-550.
26. Price EM, Lingrel JB. Structure-function relationships in the Na K-ATPase α subunit: site-directed mutagenesis of glutamine-l l l to arginine and asparagine-112 to aspartic acid generates a ouabain-resistant enzyme. Biochemistry 1988;27:8400-8.
27. Dennis JW. Effects of swainsonine and polyinosinic:-polycytidylic acid on murine tumor cell growth and metastasis. Cancer Res 1986;46:5131-6.
28. Zhang Y, Zhao JH, Zhang XY, Guo HB, Liu F, Chen HL. Relations of the type and branch of surface N-glycans to cell adhesion, migration and integrin expressions. Mol Cell Biochem 2004;260:137-46.
29. Mawji IA, Simpson CD, Hurren R, et al. Critical role for Fas-associated death domain-like interleukin-1-converting enzyme-like inhibitory protein in anoikis resistance and distant tumor formation. J Natl Cancer Inst 2007;99:811-22.
30. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nat Rev Cancer 2005;5:796-806.
31. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 2000;6:306-12.
32. Lin H, Juang JL, Wang PS. Involvement of Cdk5/p25 in digoxin-triggered prostate cancer cell apoptosis. J Biol Chem 2004;279:29302-7.
33. Kometiani P, Liu L, Askari A. Digitalis-induced signaling by Na+/K+-ATPase in human breast cancer cells. Mol Pharmacol 2005;67:929-36.
34. The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group. N Engl J Med 1997;336:525-33.
35. Dennis JW, Koch K, Yousefi S, VanderElst I. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine. Cancer Res 1990;50:1867-72.
36. Goss PE, Baptiste J, Fernandes B, Baker M, Dennis JW. A phase I study of swainsonine in patients with advanced malignancies. Cancer Res 1994;54:1450-7.
37. Goss PE, Reid CL, Bailey D, Dennis JW. Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies. Clin Cancer Res 1997;3:1077-86.
38. Narasimhan S, Wilson JR, Martin E, Schachter H. A structural basis for four distinct elution profiles on concanavalin A-Sepharose affinity chromatography of glycopeptides. Can J Biochem 1979;57:83-96.
39. Cummings RD. Use of lectins in analysis of glycoconjugates. Methods Enzymol 1994;230:66-86.
40. Dell A, Reason AJ, Khoo KH, Panico M, McDowell RA, Morris HR. Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol 1994;230:108-32.